The expanding demand for controlled immunological research and therapeutic design has spurred significant advances in recombinant signal molecule generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently manufactured using diverse expression methods, including prokaryotic hosts, mammalian cell lines, and bacu